111 – 120 of 143
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Hospital admission rates among men and women with symptoms of chronic bronchitis and airflow limitation corresponding to the GOLD stages of chronic obstructive pulmonary disease - A population-based study
(
- Contribution to journal › Article
-
Mark
Discovery of a potent and long-acting bronchorelaxing capsazepinoid, RESPIR 4-95
(
- Contribution to journal › Article
-
Mark
Increased risk of both ulcerative colitis and Crohn's disease in a population suffering from COPD
(
- Contribution to journal › Article
-
Mark
Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study
(
- Contribution to journal › Article
- 2007
-
Mark
Respiratory symptoms and lung function in 30-year-old individuals with alpha-1-antitrypsin deficiency.
(
- Contribution to journal › Article
-
Mark
Effect of inhaled corticosteroids on forearm bone mineral density: The HUNT Study, Norway
(
- Contribution to journal › Article
-
Mark
Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma
(
- Contribution to journal › Article
-
Mark
Retrospective incremental cost analysis of a hospital-based COPD Disease Management Programme in Sweden
(
- Contribution to journal › Article
-
Mark
Effects of capsazepine on human small airway responsiveness unravel a novel class of bronchorelaxants.
(
- Contribution to journal › Article
- 2006
-
Mark
Predictors of lung function and its decline in mild to moderate COPD in association with gender: Results from the Euroscop study
(
- Contribution to journal › Article